DK493487D0 - Retrovirus,der kan fremkalde aids,samt fremgangsmaade og middel til paavisning af dette retrovirus in vitro - Google Patents

Retrovirus,der kan fremkalde aids,samt fremgangsmaade og middel til paavisning af dette retrovirus in vitro

Info

Publication number
DK493487D0
DK493487D0 DK4934/87A DK493487A DK493487D0 DK 493487 D0 DK493487 D0 DK 493487D0 DK 4934/87 A DK4934/87 A DK 4934/87A DK 493487 A DK493487 A DK 493487A DK 493487 D0 DK493487 D0 DK 493487D0
Authority
DK
Denmark
Prior art keywords
retrovirus
vitro
medicine
procedure
determining
Prior art date
Application number
DK4934/87A
Other languages
English (en)
Other versions
DK175959B1 (da
DK493487A (da
Inventor
Luc Montagnier
Solange Chamaret
Denise Guetard
Marc Alizon
Francois Clavel
Mireille Guyader
Pierre Sonigo
Francoise Brun-Vezinet
Marianne Rey
Christine Rouzioux
Christine Katlama
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27576220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK493487(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR8600910A external-priority patent/FR2593189B1/fr
Priority claimed from FR8600911A external-priority patent/FR2593190B1/fr
Priority claimed from FR8601635A external-priority patent/FR2593922B1/fr
Priority claimed from FR8601985A external-priority patent/FR2594229B1/fr
Priority claimed from US06/835,228 external-priority patent/US4839288A/en
Priority claimed from FR8603881A external-priority patent/FR2596063B1/fr
Priority claimed from FR8604215A external-priority patent/FR2597500B1/fr
Publication of DK493487D0 publication Critical patent/DK493487D0/da
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of DK493487A publication Critical patent/DK493487A/da
Priority to DK200500170A priority Critical patent/DK176253B1/da
Publication of DK175959B1 publication Critical patent/DK175959B1/da
Application granted granted Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
DK198704934A 1986-01-22 1987-09-21 Human HIV-2 retrovirus, der kan fremkalde AIDS, samt fremgangsmåde og middel til påvisning af dettte retrovirus in vitro DK175959B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200500170A DK176253B1 (da) 1986-01-22 2005-02-04 Præparat, fremgangsmåde og kit til påvisning af antistoffer mod et humant retrovirus in vitro

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
FR8600911 1986-01-22
FR8600910A FR2593189B1 (fr) 1986-01-22 1986-01-22 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8600910 1986-01-22
FR8600911A FR2593190B1 (fr) 1986-01-22 1986-01-22 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8601635A FR2593922B1 (fr) 1986-02-06 1986-02-06 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8601635 1986-02-06
FR8601985A FR2594229B1 (fr) 1986-02-13 1986-02-13 Nouveau retrovirus du type lav-ii susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8601985 1986-02-13
US83522886 1986-03-03
US06/835,228 US4839288A (en) 1986-01-22 1986-03-03 Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
FR8603881A FR2596063B1 (fr) 1986-03-18 1986-03-18 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8603881 1986-03-18
FR8604215A FR2597500B1 (fr) 1986-03-24 1986-03-24 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8604215 1986-03-24
US91608086A 1986-10-06 1986-10-06
US91608086 1986-10-06
US93318486A 1986-11-21 1986-11-21
US93318486 1986-11-21
PCT/FR1987/000025 WO1987004459A1 (fr) 1986-01-22 1987-01-22 Retrovirus du type hiv-2 susceptible de provoquer le sida, et ses constituants antigeniques et nucleiques
FR8700025 1987-01-22

Publications (3)

Publication Number Publication Date
DK493487D0 true DK493487D0 (da) 1987-09-21
DK493487A DK493487A (da) 1987-11-17
DK175959B1 DK175959B1 (da) 2005-08-29

Family

ID=27576220

Family Applications (2)

Application Number Title Priority Date Filing Date
DK198704934A DK175959B1 (da) 1986-01-22 1987-09-21 Human HIV-2 retrovirus, der kan fremkalde AIDS, samt fremgangsmåde og middel til påvisning af dettte retrovirus in vitro
DK200500170A DK176253B1 (da) 1986-01-22 2005-02-04 Præparat, fremgangsmåde og kit til påvisning af antistoffer mod et humant retrovirus in vitro

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK200500170A DK176253B1 (da) 1986-01-22 2005-02-04 Præparat, fremgangsmåde og kit til påvisning af antistoffer mod et humant retrovirus in vitro

Country Status (15)

Country Link
EP (2) EP0320495B1 (da)
JP (7) JP2611106B2 (da)
AR (1) AR243931A1 (da)
AT (2) ATE47725T1 (da)
AU (1) AU601397B2 (da)
DE (3) DE3760912D1 (da)
DK (2) DK175959B1 (da)
ES (1) ES2150897T3 (da)
GR (3) GR880300056T1 (da)
HK (1) HK62091A (da)
NZ (1) NZ219024A (da)
OA (1) OA08468A (da)
PT (1) PT84182B (da)
SG (1) SG28591G (da)
WO (1) WO1987004459A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249611A4 (en) * 1985-11-14 1988-04-26 Harvard College T-LYMPHOTROPHIC VIRUS.
EP0750041B1 (fr) * 1987-01-16 2008-12-10 Institut Pasteur Séquences de nucléotides de HIV-2 et SIV-1
DE3855947T2 (de) * 1987-01-16 1997-12-11 Pasteur Institut Peptide mit den immunologischen Eigenschaften von HIV-2
AU620804B2 (en) * 1987-03-23 1992-02-27 Hiver Limited Novel vaccines
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
ATE87487T1 (de) * 1987-11-16 1993-04-15 Hoffmann La Roche Rekombinante hiv-2 polypeptide.
WO1989006276A2 (en) * 1988-01-08 1989-07-13 Dpz Deutsches Primatenzentrum Gesellschaft Mbh Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
US6197496B1 (en) 1988-06-09 2001-03-06 Institut Pasteur Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80
EP1369427A3 (en) * 1988-06-09 2004-05-12 Innogenetics N.V. HIV-3 retrovirus strains and their use
US5208321A (en) 1988-06-09 1993-05-04 Institut Pasteur HIV-2 transmembrane glycoprotein homodimer (GP 80)
EP0345559A3 (en) * 1988-06-10 1990-07-11 Abbott Laboratories Hiv-2 variants
DE68927025T2 (de) † 1988-06-14 1997-03-27 Qiagen Gmbh HIV-2-Virusvarianten
ATE136789T1 (de) * 1989-05-12 1996-05-15 Pasteur Institut Antigene eines transmembranen hüllenglycoproteins eines menschlichen retrovirus des typs hiv-2 und immunologisch verwandte antigene
FR2646854A1 (fr) * 1989-05-12 1990-11-16 Pasteur Institut Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique
DE68925202T2 (de) * 1989-05-31 1996-06-05 Pasteur Institut HIV-2-EHO-Retrovirus-Proteine und -Glycoproteine, Antikörper gegen sie, Verwendung für diagnostische Zwecke
ES2275451T3 (es) * 1989-06-02 2009-02-16 Institut Pasteur Secuencias nucleotidicas procedentes del genoma de los retrovirus del tipo vih-1,vih-2 y siv, y sus aplicaciones especialmente para la amplificacion de los genomas de estos retrovirus y para el diagnostico in vitro de las infecciones debidas a estos virus.
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
FR2647809B1 (fr) * 1989-06-02 1991-09-20 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
US7022814B1 (en) 1992-01-21 2006-04-04 Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
EP0438332B1 (fr) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
ATE105857T1 (de) 1990-06-15 1994-06-15 Innogenetics Nv Siv cpz-ant retrovirus und seine anwendungen.
GB9108652D0 (en) * 1991-04-23 1991-06-12 Antisoma Ltd Immunoreactive compounds
CA2107732C (en) * 1992-10-06 2003-04-08 Lutz G. Gurtler Retrovirus from the hiv group and its use
DE4233646C2 (de) * 1992-10-06 2003-10-23 Dade Behring Marburg Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US5962665A (en) * 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
FR2767337B1 (fr) 1997-08-14 2002-07-05 Pasteur Institut Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
CA2422956C (en) 2000-10-23 2010-10-19 Gen-Probe Incorporated Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
CA2547750C (en) 2003-12-19 2014-04-08 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of hiv-1 and hiv-2
JP6721772B1 (ja) 2019-03-26 2020-07-15 斉藤　幹雄 清掃装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
ATE250083T1 (de) * 1984-10-18 2003-10-15 Pasteur Institut Lav-antigene und -peptide
US4600413A (en) * 1984-12-10 1986-07-15 Sundstrand Corporation Centrifugal deaerator and pump
JP3105581B2 (ja) * 1991-07-03 2000-11-06 内橋エステック株式会社 面状温度ヒュ−ズ

Also Published As

Publication number Publication date
JP2771519B2 (ja) 1998-07-02
DE239425T1 (de) 1988-06-30
DK176253B1 (da) 2007-04-30
JP2931294B2 (ja) 1999-08-09
JP2735521B2 (ja) 1998-04-02
EP0239425A1 (fr) 1987-09-30
NZ219024A (en) 1990-04-26
ATE47725T1 (de) 1989-11-15
ES2150897T3 (es) 2000-12-16
PT84182A (pt) 1987-02-01
EP0239425B1 (fr) 1989-11-02
JPH0975092A (ja) 1997-03-25
GR880300056T1 (en) 1988-10-18
PT84182B (pt) 1989-09-14
DE3752319T2 (de) 2001-03-15
AU601397B2 (en) 1990-09-13
JP2801162B2 (ja) 1998-09-21
DK200500170A (da) 2005-02-04
JPH08113598A (ja) 1996-05-07
AR243931A1 (es) 1993-09-30
DK175959B1 (da) 2005-08-29
JPH06113833A (ja) 1994-04-26
JPH0937778A (ja) 1997-02-10
GR3034708T3 (en) 2001-01-31
DE3752319D1 (de) 2000-09-07
AU6891187A (en) 1987-08-14
ATE195148T1 (de) 2000-08-15
DK493487A (da) 1987-11-17
DE3760912D1 (en) 1989-12-07
HK62091A (en) 1991-08-16
EP0320495A1 (fr) 1989-06-14
OA08468A (fr) 1988-07-29
JPH1118768A (ja) 1999-01-26
JPH08275783A (ja) 1996-10-22
WO1987004459A1 (fr) 1987-07-30
JPH07233196A (ja) 1995-09-05
JP2874846B2 (ja) 1999-03-24
SG28591G (en) 1993-02-19
GR3001096T3 (en) 1992-04-17
JP2611106B2 (ja) 1997-05-21
EP0320495B1 (fr) 2000-08-02

Similar Documents

Publication Publication Date Title
DK493487D0 (da) Retrovirus,der kan fremkalde aids,samt fremgangsmaade og middel til paavisning af dette retrovirus in vitro
DK148388A (da) Blandeapparat og fremgangsmaade til fremstilling af dette
DK477686A (da) Heteropolysaccharid, fremgangsmaade til fremstilling deraf og anvendelse deraf i et kompleks samt fremgangsmaade til fremstilling af et saadant kompleks
DK298789A (da) Blaesestoebt flaske i et stykke og fremgangsmaade til fremstilling af samme
DK461387A (da) Fremgangsmaade til fremstilling af optegnelsesark og anvendelse deraf til fremstilling af flexotrykforme.
DE3751541T2 (de) Anzeigeverfahren.
DK546788D0 (da) Fremgangsmaade og anordning ti oparbejdning af flyveaske
DK581688A (da) L-tyrosinderivater og fremgangsmaade til fremstilling af samme
DK41590A (da) Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme
NO883055D0 (no) Karbosilanpolymerer og fremgangsmaate for deres fremstilling.
DK232489A (da) Apparat og fremgangsmaade til udtagning af fiskeben
DK102588A (da) Fremgangsmaade til sterilisering af emner og steriliseringsapparat til udfoerelse af fremgangsmaaden
DK628187D0 (da) Raspeapparat og fremgangsmaade til fremstilling af samme
NO904898D0 (no) Baaren filtreringsmembran og fremgangsmaate for fremstilling av denne.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK538488D0 (da) Pulverformigt yttrium-stabiliseret zirconiumoxid og fremgangsmaade til fremstilling af dette
NO165421C (no) Fremgangsmaate og anordning for avskinning.
DK161187A (da) 5-phenyl-5h-indenooe1,2-daapyrimidin og derivater deraf samt fremgangsmaade til fremstilling af saadanneforbindelser.
DK31188D0 (da) Bakterielyserende enzymprodukt, fremstilling deraf samt anvendelse af dette
DK693287A (da) Fremgangsmaade til fremstilling af lipophile aminosyrederivater, samt herved opnaaede aminosyrederivater og anvendelsen heraf
DK152087A (da) Indretning og fremgangsmaade til indstilling af tandlaegestol
DK591687A (da) Pyrazoliner, fremstilling deraf og anvendelse deraf som middel med insekticid og akarizid virkning
DK524588A (da) Middel til behandling af aids
DK82188A (da) Middel og fremgangsmaade til stabilisering af o-halogenpyridylphosphater
DK464387A (da) Fastgoerelsesorgan og fremgangsmaade til fremstilling af dette

Legal Events

Date Code Title Description
PUP Patent expired